Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm3
Judith S. Currier(University of California, Los Angeles), Risa M. Hoffman(University of California, Los Angeles), Breno Santos(Hospital Nossa Senhora da Conceição), Devasena Gnanashanmugam(Johns Hopkins University), Anne Coletti(Family Health International 360), David E. Shapiro(Intercept Pharmaceuticals (United States)), Sean S. Brummel(Harvard University), Karin L. Klingman(National Institutes of Health), José Henrique Pilotto(Universidade Iguaçu), Nahida Chakhtoura(National Institutes of Health), Adriana Weinberg(University of Colorado Anschutz Medical Campus), Marcelo Losso(UCLA Medical Center), Linda Aurpibul(Chiang Mai University), Gaerolwe Masheto(Botswana Harvard AIDS Institute Partnership), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Esaú João(Hospital Federal dos Servidores do Estado), Paula Britto(Cancer Research And Biostatistics), Marie Flore Pierre(Gheskio Centers), Renee Browning(Johns Hopkins University)
Cited by 30
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k